We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Integrated Syringe System Protects Highly Sensitive Compounds

By HospiMedica International staff writers
Posted on 26 Jul 2015
A novel closure system for prefilled syringes comes with a ready-to-use integrated needle, offering safer use of highly-sensitive compounds such as biologics. More...


The Vetter-Ject syringe closure system consists of a needle hub, an integrated staked needle, and a needle shield with a tamper-evident closure system that visibly and permanently reveals attempts at opening it to the naked eye; when the needle shield is removed, the plastic bridges are broken. Complete sterile fill and final packaging of the syringe system are provided as part of the primary packaging service, including a wide range of optional stoppers, trays, and plunger rod assemblies. The company can also provide complete auto-injector assembly.

The Vetter-Ject is manufactured by means of a two-component injection molding process based on polypropylene and a thermoplastic elastomer. An individually adaptable siliconization process means less silicon oil than commonly used is necessary for coating the glass barrel, making it particularly suitable for silicon-sensitive drug products, as the amount of silicon used and the related particle load can be reduced by up to 80%, when compared to the standard siliconization process applied to conventional syringe systems. The Vetter-Ject syringe closure system is a product of Vetter (Ravensburg, Germany).

“Vetter-Ject is ready-to-use with an integrated needle that is simple to handle and user-friendly. Our patented syringe closure system offers pharmaceutical and biotech companies more options for filling highly sensitive parenteral drugs,” said Tilman Roedle, director of packaging development at Vetter. “Patients and qualified medical personnel now have the advantage of the system's easy handling and high standards for product safety and integrity.”

The siliconization of glass vials has three advantages. It minimizes the interactions between the product and container; it prevents high viscosity products from sticking to the internal surface of the vials, giving the glass bottle a prefect transparency; and due to its hydrophobic properties, the silicone coating ensures a higher restitution rate of the product. The resistance of the silicone coating depends on the chemical structure of the product formulation, as well as its dissolving power on silicone.

Related Links:

Vetter



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Mammography System (Analog)
MAM VENUS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.